ABL1 and neoplasm: In this study, these titular compounds were evaluated to be Abl-kinase inhibitors as the Abl family of proteins are known to influence growth, survival, invasion, and angiogenesis during tumor initiation and progression (Lin and Arlinghaus 2008).